Published in Infect Control Hosp Epidemiol on March 01, 2010
Fidaxomicin to Prevent Clostridium Difficile Colonization | NCT01552668
Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol (2011) 1.83
The economic burden of Clostridium difficile. Clin Microbiol Infect (2011) 1.74
Statin use and the risk of Clostridium difficile in academic medical centres. Gut (2012) 1.55
The transition to ICD-10-CM: challenges for pediatric practice. Pediatrics (2014) 1.19
The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections. Clin Infect Dis (2011) 1.16
Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates. Infect Control Hosp Epidemiol (2013) 1.10
Reduction in Clostridium difficile infection rates after mandatory hospital public reporting: findings from a longitudinal cohort study in Canada. PLoS Med (2012) 1.01
Surveillance for Clostridium difficile infection: ICD-9 coding has poor sensitivity compared to laboratory diagnosis in hospital patients, Singapore. PLoS One (2011) 0.97
Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis. Liver Transpl (2012) 0.90
Temporal phenome analysis of a large electronic health record cohort enables identification of hospital-acquired complications. J Am Med Inform Assoc (2013) 0.87
Accuracy of ICD-10 codes for surveillance of Clostridium difficile infections, France. Emerg Infect Dis (2012) 0.86
A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006. Infect Control Hosp Epidemiol (2012) 0.85
Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection. Infect Control Hosp Epidemiol (2016) 0.77
Epidemiology of Clostridium difficile infection among active duty United States military personnel (1998-2010). BMC Infect Dis (2013) 0.75
Prevalence and Predictors of Postdischarge Antibiotic Use Following Mastectomy. Infect Control Hosp Epidemiol (2017) 0.75
An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med (2005) 18.10
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ (2004) 9.93
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis (2006) 7.64
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis (2005) 7.16
Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol (2007) 5.37
A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol (2005) 5.26
Assessing comorbidity using claims data: an overview. Med Care (2002) 4.94
Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg (2002) 4.91
Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis (2004) 3.42
ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis (2006) 2.27
Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect (2006) 1.76
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99
Targeted versus universal decolonization to prevent ICU infection. N Engl J Med (2013) 13.05
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet (2005) 12.54
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med (2013) 7.75
A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med (2005) 6.14
Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother (2003) 5.48
Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis (2011) 5.42
Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother (2005) 5.35
Patients' and physicians' attitudes regarding the disclosure of medical errors. JAMA (2003) 4.94
Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis (2008) 4.92
Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis (2009) 4.87
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis (2005) 4.52
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis (2003) 4.29
An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis (2010) 4.06
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest (2002) 3.98
Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis (2008) 3.95
Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest (2009) 3.70
Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am (2008) 3.53
Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother (2005) 3.49
Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis (2007) 3.21
Burden of Clostridium difficile on the healthcare system. Clin Infect Dis (2012) 3.20
Current status of Clostridium difficile infection epidemiology. Clin Infect Dis (2012) 3.14
Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 3.13
Healthcare personnel attire in non-operating-room settings. Infect Control Hosp Epidemiol (2014) 3.10
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin Infect Dis (2006) 2.98
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med (2013) 2.78
Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med (2006) 2.76
Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis (2009) 2.74
Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis (2008) 2.61
Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med (2003) 2.59
Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2006) 2.57
Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA (2013) 2.55
Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis (2006) 2.43
Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections. Am J Infect Control (2008) 2.38
Characteristics and circumstances of falls in a hospital setting: a prospective analysis. J Gen Intern Med (2004) 2.37
The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis (2012) 2.34
Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.30
ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis (2006) 2.27
A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest (2004) 2.26
Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis (2009) 2.24
Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA (2010) 2.23
Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.22
Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis (2011) 2.22
Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol (2006) 2.19
Risk factors for surgical site infection in spinal surgery. J Neurosurg (2003) 2.17
Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med (2012) 2.17
Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteria. Infect Control Hosp Epidemiol (2012) 2.15
Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Clin Infect Dis (2011) 2.15
Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol (2004) 2.13
Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis (2007) 2.07
Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis (2011) 2.01
Serum transaminases are frequently elevated at time of diagnosis of idiopathic inflammatory myopathy and normalize with creatine kinase. J Clin Rheumatol (2014) 2.01
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob Agents Chemother (2007) 2.01
Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol (2009) 2.00
Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis (2008) 1.98
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis (2006) 1.97
Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis (2009) 1.95
Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis. Clin Infect Dis (2005) 1.95
A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol (2006) 1.93
Community-associated methicillin-resistant Staphylococcus aureus colonization burden in HIV-infected patients. Clin Infect Dis (2013) 1.92
Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med (2006) 1.91
Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol (2002) 1.90
Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics (2005) 1.89
Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.84
Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol (2011) 1.83
Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.81
Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol (2008) 1.78
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis (2014) 1.78
Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics (2003) 1.76
Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.75
The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med (2010) 1.73
Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol (2010) 1.73
Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med (2002) 1.72
Choosing your words carefully: how physicians would disclose harmful medical errors to patients. Arch Intern Med (2006) 1.69
Risk factors for surgical site infection after low transverse cesarean section. Infect Control Hosp Epidemiol (2008) 1.69
Risk managers, physicians, and disclosure of harmful medical errors. Jt Comm J Qual Patient Saf (2010) 1.69